CD99 was found to be highly expressed in ependymomas [78,79], in malignant gliomas [5], and in astrocytomas [5,6], where its detection can help discriminate among tumor grades, with a differential subcellular distribution according to the malignancy stage. This evidence concerns the gene CD99 and neoplasm.